A classic Kaposi's sarcoma of the oral cavity. a clinical case
Bonetta, A.; Zini, G.; Serra, L.; Iotti, C.; Armaroli, L.
La Radiologia Medica 89(4): 543-545
1995
ISSN/ISBN: 0033-8362 PMID: 7597243 Document Number: 453025
Document emailed within 1 workday
Related Documents
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663Invernizzi, R.; Ubiali, P.; Barcella, A.; Bonzanini, C. 1993: Kaposi's sarcoma--classic form. a rare familial case Minerva Chirurgica 48(5): 237-241
Santucci, M.; Pimpinelli, N.; Moretti, S.; Giannotti, B. 1988: Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic, and immunologic correlations Archives of Pathology and Laboratory Medicine 112(12): 1214-1220
Mohanna, S.; Maco, V.; Gown, A.; Morales, D.; Bravo, F.; Gotuzzo, E. 2006: Is classic Kaposi's sarcoma endemic in Peru?: report of a case in an indigenous patient American Journal of Tropical Medicine and Hygiene 75(2): 324-326
Wahman, A.; Melnick, S.L.; Rhame, F.S.; Potter, J.D. 1991: The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma Epidemiologic Reviews 13: 178-199
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206
Piazzi, M.; Bonazzi, V.; Degli Esposti, R. 1991: The clinical aspects of 4 cases of oral Kaposi's sarcoma Minerva Stomatologica 40(10): 675-679
Naidu, A.; Havard, D.B.; Ray, J.Michael.; Wright, J.M. 2011: Oral and maxillofacial pathology case of the month. Kaposi's sarcoma Texas Dental Journal 128(4): 376-7 382-3
Barberis, M.; Brenna Betti, N.; Lauritano, D.; Sangiani, L.; Spadari, F.; Villa, S. 1996: Oral lesions in Kaposi sarcoma: clinical and radiotherapeutic considerations Minerva Stomatologica 45(1-2): 17-27
Hille, J.J.; Phillips, J.I.; Petit, J.C.; Simpson, R.H. 1985: Oral Kaposi's sarcoma in a patient with the acquired immune deficiency syndrome. A case report with notes on management and safety Journal of the Dental Association of South Africa 40(6): 321-325
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Moyle, G.; Youle, M.; Barton, S. 1993: Intralesional vinblastine in the treatment of oral Kaposi's sarcoma British Journal of Clinical Practice 47(2): 79-80
Beckstead, J.H. 1992: Oral presentation of Kaposi's sarcoma in a patient without severe immunodeficiency Archives of Pathology and Laboratory Medicine 116(5): 543-545
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Marimo, C. 2008: Epidemiology of oral Kaposi's sarcoma in Zimbabwe 1988-1997: a population-based study Central African journal of medicine 54(1-4): 15-19
Carpenter, W.M. 1997: Case 4: Kaposi's sarcoma Journal of the California Dental Association 25(8): 559-562; 578
Pagnacco, A.; Randon, C.; Vangelisti, R.; Ferrara, M. 1988: Coxsackiosis of the oral cavity. Description of a clinical case Dental Cadmos 56(20): 83-85
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679